Wedbush Initiates Coverage On Alto Neuroscience with Outperform Rating, Announces Price Target of $29
Portfolio Pulse from Benzinga Newsdesk
Wedbush analyst Laura Chico has initiated coverage on Alto Neuroscience with an Outperform rating and set a price target of $29.
September 03, 2024 | 3:44 pm
News sentiment analysis
Sort by:
Ascending
POSITIVE IMPACT
Wedbush has initiated coverage on Alto Neuroscience with an Outperform rating and a price target of $29, indicating a positive outlook.
The initiation of coverage with an Outperform rating and a specific price target of $29 by a reputable analyst can positively influence investor sentiment and potentially drive the stock price up in the short term.
CONFIDENCE 90
IMPORTANCE 80
RELEVANCE 100